Upcoming Dividend • May 21
Upcoming dividend of JP¥55.00 per share Eligible shareholders must have bought the stock before 28 May 2026. Payment date: 31 August 2026. Payout ratio is a comfortable 26% and this is well supported by cash flows. Trailing yield: 3.2%. Lower than top quartile of Japanese dividend payers (3.8%). Higher than average of industry peers (1.9%). Reported Earnings • Apr 11
Third quarter 2026 earnings released: EPS: JP¥48.87 (vs JP¥47.14 in 3Q 2025) Third quarter 2026 results: EPS: JP¥48.87 (up from JP¥47.14 in 3Q 2025). Revenue: JP¥1.96b (up 7.8% from 3Q 2025). Net income: JP¥142.0m (up 3.6% from 3Q 2025). Profit margin: 7.2% (down from 7.5% in 3Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 8% per year whereas the company’s share price has increased by 5% per year. Duyuru • Apr 03
CNS Co.,Ltd to Report Q3, 2026 Results on Apr 10, 2026 CNS Co.,Ltd announced that they will report Q3, 2026 results on Apr 10, 2026 Buy Or Sell Opportunity • Mar 23
Now 20% undervalued after recent price drop Over the last 90 days, the stock has fallen 4.7% to JP¥1,644. The fair value is estimated to be JP¥2,063, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 8.4% over the last 3 years. Earnings per share has grown by 7.4%. Buy Or Sell Opportunity • Feb 24
Now 20% undervalued Over the last 90 days, the stock has risen 1.8% to JP¥1,690. The fair value is estimated to be JP¥2,122, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 8.4% over the last 3 years. Earnings per share has grown by 7.4%. Buy Or Sell Opportunity • Feb 04
Now 20% undervalued Over the last 90 days, the stock has risen 4.9% to JP¥1,712. The fair value is estimated to be JP¥2,141, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 8.4% over the last 3 years. Earnings per share has grown by 7.4%. Reported Earnings • Jan 10
Second quarter 2026 earnings released: EPS: JP¥40.95 (vs JP¥37.16 in 2Q 2025) Second quarter 2026 results: EPS: JP¥40.95 (up from JP¥37.16 in 2Q 2025). Revenue: JP¥1.88b (up 9.2% from 2Q 2025). Net income: JP¥119.0m (up 10% from 2Q 2025). Profit margin: 6.3% (in line with 2Q 2025). Over the last 3 years on average, earnings per share has increased by 7% per year whereas the company’s share price has increased by 11% per year. Duyuru • Nov 20
CNS Co.,Ltd to Report Q2, 2026 Results on Jan 09, 2026 CNS Co.,Ltd announced that they will report Q2, 2026 results on Jan 09, 2026 Reported Earnings • Oct 11
First quarter 2026 earnings released: EPS: JP¥52.99 (vs JP¥18.58 in 1Q 2025) First quarter 2026 results: EPS: JP¥52.99 (up from JP¥18.58 in 1Q 2025). Revenue: JP¥1.87b (up 14% from 1Q 2025). Net income: JP¥154.0m (up 185% from 1Q 2025). Profit margin: 8.2% (up from 3.3% in 1Q 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 6% per year whereas the company’s share price has increased by 8% per year. Buy Or Sell Opportunity • Sep 10
Now 20% overvalued The stock has been flat over the last 90 days, currently trading at JP¥1,546. The fair value is estimated to be JP¥1,283, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 9.0% over the last 3 years, while earnings per share has been flat. Reported Earnings • Sep 02
Full year 2025 earnings released: EPS: JP¥147 (vs JP¥159 in FY 2024) Full year 2025 results: EPS: JP¥147 (down from JP¥159 in FY 2024). Revenue: JP¥7.00b (up 5.2% from FY 2024). Net income: JP¥427.0m (down 7.4% from FY 2024). Profit margin: 6.1% (down from 6.9% in FY 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 2% per year whereas the company’s share price has increased by 1% per year. Duyuru • Jul 29
CNS Co.,Ltd to Report Q1, 2026 Results on Oct 10, 2025 CNS Co.,Ltd announced that they will report Q1, 2026 results on Oct 10, 2025 Reported Earnings • Jul 14
Full year 2025 earnings released: EPS: JP¥147 (vs JP¥159 in FY 2024) Full year 2025 results: EPS: JP¥147 (down from JP¥159 in FY 2024). Revenue: JP¥7.00b (up 5.2% from FY 2024). Net income: JP¥427.0m (down 7.4% from FY 2024). Profit margin: 6.1% (down from 6.9% in FY 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 2% per year whereas the company’s share price has fallen by 1% per year. Duyuru • Jul 11
CNS Co.,Ltd, Annual General Meeting, Aug 28, 2025 CNS Co.,Ltd, Annual General Meeting, Aug 28, 2025. Upcoming Dividend • May 22
Upcoming dividend of JP¥75.00 per share Eligible shareholders must have bought the stock before 29 May 2025. Payment date: 01 September 2025. Payout ratio is a comfortable 34% and this is well supported by cash flows. Trailing yield: 2.9%. Lower than top quartile of Japanese dividend payers (4.0%). Higher than average of industry peers (1.3%). Duyuru • May 09
CNS Co.,Ltd to Report Fiscal Year 2025 Results on Jul 11, 2025 CNS Co.,Ltd announced that they will report fiscal year 2025 results on Jul 11, 2025 Reported Earnings • Apr 12
Third quarter 2025 earnings released: EPS: JP¥47.14 (vs JP¥44.74 in 3Q 2024) Third quarter 2025 results: EPS: JP¥47.14 (up from JP¥44.74 in 3Q 2024). Revenue: JP¥1.82b (up 8.2% from 3Q 2024). Net income: JP¥137.0m (up 5.4% from 3Q 2024). Profit margin: 7.5% (down from 7.7% in 3Q 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 1% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings. Duyuru • Feb 03
CNS Co.,Ltd to Report Q3, 2025 Results on Apr 11, 2025 CNS Co.,Ltd announced that they will report Q3, 2025 results on Apr 11, 2025 Reported Earnings • Jan 15
Second quarter 2025 earnings released: EPS: JP¥37.16 (vs JP¥45.08 in 2Q 2024) Second quarter 2025 results: EPS: JP¥37.16 (down from JP¥45.08 in 2Q 2024). Revenue: JP¥1.72b (up 4.2% from 2Q 2024). Net income: JP¥108.0m (down 18% from 2Q 2024). Profit margin: 6.3% (down from 7.9% in 2Q 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 2% per year whereas the company’s share price has fallen by 2% per year. Duyuru • Oct 26
CNS Co.,Ltd to Report Q2, 2025 Results on Jan 10, 2025 CNS Co.,Ltd announced that they will report Q2, 2025 results on Jan 10, 2025 Board Change • Oct 23
Less than half of directors are independent Following the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Outside Director Noriaki Onishi was the last independent director to join the board, commencing their role in 2023. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Oct 16
First quarter 2025 earnings released: EPS: JP¥18.58 (vs JP¥30.63 in 1Q 2024) First quarter 2025 results: EPS: JP¥18.58 (down from JP¥30.63 in 1Q 2024). Revenue: JP¥1.64b (flat on 1Q 2024). Net income: JP¥54.0m (down 39% from 1Q 2024). Profit margin: 3.3% (down from 5.4% in 1Q 2024). New Risk • Sep 17
New major risk - Financial data availability The company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (JP¥4.41b market cap, or US$31.3m). Valuation Update With 7 Day Price Move • Aug 05
Investor sentiment deteriorates as stock falls 23% After last week's 23% share price decline to JP¥1,335, the stock trades at a trailing P/E ratio of 8.4x. Average trailing P/E is 17x in the IT industry in Japan. Total loss to shareholders of 29% over the past year. Reported Earnings • Jul 16
Full year 2024 earnings released: EPS: JP¥159 (vs JP¥149 in FY 2023) Full year 2024 results: EPS: JP¥159 (up from JP¥149 in FY 2023). Revenue: JP¥6.66b (up 11% from FY 2023). Net income: JP¥461.0m (up 6.5% from FY 2023). Profit margin: 6.9% (down from 7.2% in FY 2023). The decrease in margin was driven by higher expenses. Upcoming Dividend • May 23
Upcoming dividend of JP¥48.00 per share Eligible shareholders must have bought the stock before 30 May 2024. Payment date: 28 August 2024. Payout ratio is a comfortable 28% and this is well supported by cash flows. Trailing yield: 2.6%. Lower than top quartile of Japanese dividend payers (3.4%). Higher than average of industry peers (1.6%). Duyuru • May 03
CNS Co.,Ltd to Report Fiscal Year 2024 Results on Jul 11, 2024 CNS Co.,Ltd announced that they will report fiscal year 2024 results on Jul 11, 2024 Reported Earnings • Apr 12
Third quarter 2024 earnings released: EPS: JP¥44.74 (vs JP¥43.01 in 3Q 2023) Third quarter 2024 results: EPS: JP¥44.74 (up from JP¥43.01 in 3Q 2023). Revenue: JP¥1.68b (up 11% from 3Q 2023). Net income: JP¥130.0m (up 4.0% from 3Q 2023). Profit margin: 7.7% (down from 8.2% in 3Q 2023). The decrease in margin was driven by higher expenses. Duyuru • Jan 28
CNS Co.,Ltd to Report Q3, 2024 Results on Apr 11, 2024 CNS Co.,Ltd announced that they will report Q3, 2024 results on Apr 11, 2024 Reported Earnings • Jan 13
Second quarter 2024 earnings released: EPS: JP¥45.08 (vs JP¥39.57 in 2Q 2023) Second quarter 2024 results: EPS: JP¥45.08 (up from JP¥39.57 in 2Q 2023). Revenue: JP¥1.65b (up 14% from 2Q 2023). Net income: JP¥131.0m (up 14% from 2Q 2023). Profit margin: 7.9% (down from 8.0% in 2Q 2023). The decrease in margin was driven by higher expenses. Duyuru • Oct 29
CNS Co.,Ltd to Report Q2, 2024 Results on Jan 11, 2024 CNS Co.,Ltd announced that they will report Q2, 2024 results on Jan 11, 2024 Reported Earnings • Oct 12
First quarter 2024 earnings released: EPS: JP¥30.63 (vs JP¥25.81 in 1Q 2023) First quarter 2024 results: EPS: JP¥30.63 (up from JP¥25.81 in 1Q 2023). Revenue: JP¥1.65b (up 18% from 1Q 2023). Net income: JP¥89.0m (up 19% from 1Q 2023). Profit margin: 5.4% (in line with 1Q 2023). New Risk • Aug 08
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 5.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (134% accrual ratio). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (5.5% average weekly change). Market cap is less than US$100m (JP¥5.65b market cap, or US$39.7m). Duyuru • Aug 03
CNS Co.,Ltd. to Report Q1, 2024 Results on Oct 11, 2023 CNS Co.,Ltd. announced that they will report Q1, 2024 results on Oct 11, 2023 Reported Earnings • Jul 17
Full year 2023 earnings released: EPS: JP¥149 (vs JP¥145 in FY 2022) Full year 2023 results: EPS: JP¥149 (up from JP¥145 in FY 2022). Revenue: JP¥5.99b (up 11% from FY 2022). Net income: JP¥433.0m (up 5.9% from FY 2022). Profit margin: 7.2% (down from 7.5% in FY 2022). The decrease in margin was driven by higher expenses. Duyuru • Jul 15
CNS Co.,Ltd., Annual General Meeting, Aug 25, 2023 CNS Co.,Ltd., Annual General Meeting, Aug 25, 2023. Valuation Update With 7 Day Price Move • Jul 14
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to JP¥1,921, the stock trades at a trailing P/E ratio of 14.9x. Average trailing P/E is 19x in the IT industry in Japan. Total returns to shareholders of 33% over the past year. Buying Opportunity • Jul 05
Now 21% undervalued Over the last 90 days, the stock is up 21%. The fair value is estimated to be JP¥2,096, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 8.1% over the last 3 years, while earnings per share has been flat. Upcoming Dividend • May 23
Upcoming dividend of JP¥45.00 per share at 3.1% yield Eligible shareholders must have bought the stock before 30 May 2023. Payment date: 29 August 2023. Payout ratio is a comfortable 23% and this is well supported by cash flows. Trailing yield: 3.1%. Lower than top quartile of Japanese dividend payers (3.5%). Higher than average of industry peers (1.6%). Reported Earnings • Apr 13
Third quarter 2023 earnings released: EPS: JP¥43.01 (vs JP¥40.63 in 3Q 2022) Third quarter 2023 results: EPS: JP¥43.01 (up from JP¥40.63 in 3Q 2022). Revenue: JP¥1.52b (up 13% from 3Q 2022). Net income: JP¥125.0m (up 5.9% from 3Q 2022). Profit margin: 8.2% (down from 8.7% in 3Q 2022). The decrease in margin was driven by higher expenses. Duyuru • Feb 01
CNS Co.,Ltd. to Report Q3, 2023 Results on Apr 12, 2023 CNS Co.,Ltd. announced that they will report Q3, 2023 results on Apr 12, 2023 Reported Earnings • Jan 14
Second quarter 2023 earnings released: EPS: JP¥39.57 (vs JP¥40.63 in 2Q 2022) Second quarter 2023 results: EPS: JP¥39.57 (down from JP¥40.63 in 2Q 2022). Revenue: JP¥1.44b (up 6.9% from 2Q 2022). Net income: JP¥115.0m (down 2.5% from 2Q 2022). Profit margin: 8.0% (down from 8.7% in 2Q 2022). The decrease in margin was driven by higher expenses. Duyuru • Oct 30
CNS Co.,Ltd. to Report Q2, 2023 Results on Jan 13, 2023 CNS Co.,Ltd. announced that they will report Q2, 2023 results on Jan 13, 2023 Duyuru • Aug 27
CNS Co.,Ltd. to Report Q1, 2023 Results on Oct 12, 2022 CNS Co.,Ltd. announced that they will report Q1, 2023 results on Oct 12, 2022 Duyuru • Jul 16
CNS Co.,Ltd., Annual General Meeting, Aug 26, 2022 CNS Co.,Ltd., Annual General Meeting, Aug 26, 2022. Duyuru • May 19
CNS Co.,Ltd. to Report Fiscal Year 2022 Results on Jul 14, 2022 CNS Co.,Ltd. announced that they will report fiscal year 2022 results on Jul 14, 2022 Duyuru • Feb 22
CNS Co.,Ltd. to Report Q3, 2022 Results on Apr 12, 2022 CNS Co.,Ltd. announced that they will report Q3, 2022 results on Apr 12, 2022 Valuation Update With 7 Day Price Move • Dec 15
Investor sentiment deteriorated over the past week After last week's 16% share price decline to JP¥1,433, the stock trades at a trailing P/E ratio of 12.4x. Average trailing P/E is 20x in the IT industry in Japan. Reported Earnings • Sep 06
Full year 2021 earnings released: EPS JP¥134 (vs JP¥130 in FY 2020) The company reported a solid full year result with improved earnings and revenues, although profit margins were weaker. Full year 2021 results: Revenue: JP¥4.84b (up 5.8% from FY 2020). Net income: JP¥336.0m (up 3.4% from FY 2020). Profit margin: 6.9% (down from 7.1% in FY 2020). The decrease in margin was driven by higher expenses. Duyuru • Aug 21
CNS Co.,Ltd. has completed an IPO in the amount of ¥1.0088 billion. CNS Co.,Ltd. has completed an IPO in the amount of ¥1.0088 billion.
Security Name: Common Stock
Security Type: Common Stock
Securities Offered: 520,000
Price\Range: ¥1940
Discount Per Security: ¥155.2